Clinical Trial Update: Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the efficacy of locally delivered allogeneic mesenchymal stromal cells for corneal ulcers. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ulcer

Drugs mentioned

• Locally Delivered Allogeneic Mesenchymal Stromal Cells (mesenchymal stromal cells)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Corneal Ulcer | Phase 2 | Status: RECRUITING